Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Share News (DVO)

  • There is currently no data for DVO

Non-execs show confidence in Devro

Tue, 22nd Feb 2011 16:53
Buying by Devro directors has kept the share price rising after yesterday's annual results from the sausage casings manufacturer. The shares rose a further 9% to 265.1p each. Chairman Steve Hannam bought 16,616 shares at 240p each, taking his stake to 149,306. The total investment was nearly £39,000. Hannam has been chairman since May 2009. Non-executive director Paul Neep acquired 6,070 shares at 241p each, which cost £14,629. He owns 193,593 shares in Devro. Neep, who is chief executive of LVMH subsidiary Glenmorangie, has been on the board since 2005. Devro's profit before tax and exceptional items in 2010 rose 44% to £36.3m. Reported profit before tax doubled to £55.2m from £26.9m, as 2010's results benefited from an £18.9m exceptional credit derived from a reduction in the liabilities of the group's UK defined benefit pension scheme. Operating margin improved to 16.1% from 12.4%, reflecting higher prices and a more efficient manufacturing cost base.Panmure Gordon raised its 2011 profit forecast after the figures. The earnings per share forecast was increased from 18.1p to 19.5p. Top Director BuysDevro (DVO) Director name: Mr Steve HannamAmount purchased: 16,616 @ 240.00pValue: £39,878Devro (DVO) Director name: Mr Paul NeepAmount purchased: 6,070 @ 241.00Value: £14,629Top Director SellsCarnival (CCL) Director name: Mr Peter RatcliffeAmount sold: 22,909 @ 2,838.95p Value: £650,375Carnival (CCL) Director name: Mr Pier Luigi FoschiAmount sold: 16,593 @ 2,838.95p Value: £471,067GlaxoSmithKline (GSK) Director name: Mr Simon BicknellAmount sold: 1,286 @ 1,201.00p Value: £15,445Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.64p Value: £10,410Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.62p Value: £10,405

Related News

Moderna's mRNA flu vaccine backed by FDA advisers
4 hours ago

Moderna's mRNA flu vaccine backed by FDA advisers

* ⁠FDA advisers back mFlusiva's benefits for adults 50 and up

GSK says US FDA approves urinary tract infection treatment Utebzi
1 day ago

GSK says US FDA approves urinary tract infection treatment Utebzi

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic ...

GSK drug momelotinib gains regulatory nods as VEXAS treatment
12 Jun 2026

GSK drug momelotinib gains regulatory nods as VEXAS treatment

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the Eu...

DVO.L News

IN BRIEF: Devro reports first quarter "strong growth" across markets
29 Apr 2021

IN BRIEF: Devro reports first quarter "strong growth" across markets

IN BRIEF: Devro reports first quarter "strong growth" across markets

IN BRIEF: Devro Chair Steve Good purchases GBP36,880 in shares
10 Mar 2021

IN BRIEF: Devro Chair Steve Good purchases GBP36,880 in shares

IN BRIEF: Devro Chair Steve Good purchases GBP36,880 in shares

DIRECTOR DEALINGS: StanChart HR head sells shares; Nichols CEO buys
5 Mar 2021

DIRECTOR DEALINGS: StanChart HR head sells shares; Nichols CEO buys

DIRECTOR DEALINGS: StanChart HR head sells shares; Nichols CEO buys

IN BRIEF: Devro maintains annual payout amid swing to profit
2 Mar 2021

IN BRIEF: Devro maintains annual payout amid swing to profit

IN BRIEF: Devro maintains annual payout amid swing to profit

SMALL-CAP WINNERS & LOSERS: Robert Walters profit ahead of forecasts
2 Mar 2021

SMALL-CAP WINNERS & LOSERS: Robert Walters profit ahead of forecasts

SMALL-CAP WINNERS & LOSERS: Robert Walters profit ahead of forecasts

UK Earnings, Trading Statements Calendar - Next 7 Days
23 Feb 2021

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

LONDON SMALL-CAP WINNERS & LOSERS: Funding Circle's Second Half Strong
18 Jan 2021

LONDON SMALL-CAP WINNERS & LOSERS: Funding Circle's Second Half Strong

LONDON SMALL-CAP WINNERS & LOSERS: Funding Circle's Second Half Strong

Devro's 2020 Profit To Be At Upper End Of Forecasts As Volumes Improve
18 Jan 2021

Devro's 2020 Profit To Be At Upper End Of Forecasts As Volumes Improve

Devro's 2020 Profit To Be At Upper End Of Forecasts As Volumes Improve